Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W To

Showing results (91-100 of 285) with videos related to

Pageof 29
Sort By:
Molecular Cancer Therapeutics|October 15, 2009
Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2Kenneth K W To, Robert W Robey, Turid Knutsen, et al.
Biochemical Pharmacology|July 25, 2015
Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxiaKenneth K W To, Daniel C Poon, Yuming Wei, et al.
Current Cancer Drug Targets|November 2, 2018
The RNA Binding Protein HuR: A Promising Drug Target for Anticancer TherapyMingxia Wu, Christy W S Tong, Wei Yan, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|November 26, 2019
Innate immune defect predisposing to severe influenza in a Chinese populationK K W To, J Zhou, Y Q Song, et al.
The European Respiratory Journal|October 5, 2010
Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumoniaK K W To, K-H Chan, Y-F Fung, et al.
Pharmaceutics|July 30, 2025
Recent Advances in the Use of <i>Ganoderma lucidum</i> and <i>Coriolus versicolor</i> Mushrooms to Enhance the Anticancer Efficacy of EGFR-Targeted Drugs in Lung CancerHang Zhang, Longling Wang, Yuet Wa Chan, et al.
Seminars in Cancer Biology|May 13, 2025
HDAC inhibitors: Cardiotoxicity and paradoxical cardioprotective effect in ischemia-reperfusion myocardiocyte injuryKenneth K W To, Seda S Tolu, Longling Wang, et al.
Clinical Microbiology Reviews|April 12, 2012
Two years after pandemic influenza A/2009/H1N1: what have we learned?Vincent C C Cheng, Kelvin K W To, Herman Tse, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 16, 2004
Leu-574 of human HIF-1alpha is a molecular determinant of prolyl hydroxylationYukio Kageyama, Minori Koshiji, Kenneth K W To, et al.
Bioorganic & Medicinal Chemistry|September 11, 2004
Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidinKenneth K W To, Xinning Wang, Chun Wing Yu, et al.
Pageof 29

Showing results (91-100 of 285) with videos related to

Sort By:
Pageof 29
Molecular Cancer Therapeutics|October 15, 2009
Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2Kenneth K W To, Robert W Robey, Turid Knutsen, et al.
Biochemical Pharmacology|July 25, 2015
Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxiaKenneth K W To, Daniel C Poon, Yuming Wei, et al.
Current Cancer Drug Targets|November 2, 2018
The RNA Binding Protein HuR: A Promising Drug Target for Anticancer TherapyMingxia Wu, Christy W S Tong, Wei Yan, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|November 26, 2019
Innate immune defect predisposing to severe influenza in a Chinese populationK K W To, J Zhou, Y Q Song, et al.
The European Respiratory Journal|October 5, 2010
Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumoniaK K W To, K-H Chan, Y-F Fung, et al.
Pharmaceutics|July 30, 2025
Recent Advances in the Use of <i>Ganoderma lucidum</i> and <i>Coriolus versicolor</i> Mushrooms to Enhance the Anticancer Efficacy of EGFR-Targeted Drugs in Lung CancerHang Zhang, Longling Wang, Yuet Wa Chan, et al.
Seminars in Cancer Biology|May 13, 2025
HDAC inhibitors: Cardiotoxicity and paradoxical cardioprotective effect in ischemia-reperfusion myocardiocyte injuryKenneth K W To, Seda S Tolu, Longling Wang, et al.
Clinical Microbiology Reviews|April 12, 2012
Two years after pandemic influenza A/2009/H1N1: what have we learned?Vincent C C Cheng, Kelvin K W To, Herman Tse, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 16, 2004
Leu-574 of human HIF-1alpha is a molecular determinant of prolyl hydroxylationYukio Kageyama, Minori Koshiji, Kenneth K W To, et al.
Bioorganic & Medicinal Chemistry|September 11, 2004
Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidinKenneth K W To, Xinning Wang, Chun Wing Yu, et al.
Pageof 29